ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "work"

  • Abstract Number: 1355 • ACR Convergence 2022

    Relationships Between Work Productivity, Activity Impairment, and Select Patient-Reported Outcomes in Patients with Ankylosing Spondylitis: A Post Hoc Analysis of Two Placebo-Controlled Trials

    Marina Magrey1, James Cheng-Chung WEI2, Arne Yndestad3, Andrew Bushmakin4, Joseph Cappelleri4, Oluwaseyi Dina5 and Atul Deodhar6, 1Case Western Reserve University, University Hospitals, Richfield, OH, 2Chung Shan Medical University Hospital, Taichung, Taiwan, 3Pfizer Inc, Oslo, Norway, 4Pfizer Inc, Groton, CT, 5Pfizer Inc, New York, NY, 6Oregon Health & Science University, Portland, OR, USA, Portland, OR

    Background/Purpose: Patients (pts) with AS often experience impaired work productivity.1 In pts with AS receiving tofacitinib (oral Janus kinase inhibitor), improvements were observed in work…
  • Abstract Number: 1516 • ACR Convergence 2022

    How Disease Activity Can Affect Workability in Spondyloarthropaties: A Monocentric Cohort Analysis

    Federico Fattorini1, Cosimo Cigolini2, Gabriele Marchetti3, Andrea Delle Sedie4, Linda Carli5 and Marta Mosca5, 1Rheumatology Unit, University of Pisa, Pisa, Italy, 2Rheumatology Unit, University of Pisa, Pisa, Toscana, Italy, 3University of Pisa, Pisa, Toscana, Italy, 4University of Pisa, Pisa, Pisa, Italy, 5Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, PISA, Italy

    Background/Purpose: Spondyloarthropathies (SpA) may compromise the working ability (WA) of patients, often affected by the disease during their productive life. The Work Productivity and Activity…
  • Abstract Number: 1792 • ACR Convergence 2021

    Participation in Psoriatic Arthritis (PART2) – a Cross-sectional Study of Work Impairment in Psoriatic Arthritis Patients in the Netherlands

    Tamara van Hal1, Michelle Mulder1, Mark Wenink2 and Johanna Vriezekolk1, 1Sint Maartenskliniek, Nijmegen, Netherlands, 2Sint Maartenskliniek, Malden, Netherlands

    Background/Purpose: Psoriatic arthritis (PsA) can lead to pain, disability and a loss of quality of life [Rosen, Rheumatology 2012]. PsA can also lead to impairments…
  • Abstract Number: 1826 • ACR Convergence 2021

    Reduced Burden on Paid and Household Work Productivity with Stringent Thresholds of Disease Control: Further Results from Long-Term Certolizumab Pegol Treatment in Patients with Psoriatic Arthritis

    William Tillett1, Laura Coates2, Sandeep Kiri3, Vanessa Taieb3 and Philip Mease4, 1Royal National Hospital for Rheumatic Diseases, Bath, United Kingdom, 2Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom, 3UCB Pharma, Slough, United Kingdom, 4Swedish Medical Center/Providence St. Joseph Health and University of Washington, Seattle, WA

    Background/Purpose: Psoriatic arthritis (PsA) is associated with a reduction in workplace productivity,1 which may extend into household productivity.2 Certolizumab pegol (CZP) is a tumor necrosis…
  • Abstract Number: 1926 • ACR Convergence 2021

    Effectiveness of the Making It Work™ Program at Improving Absenteeism in Workers with Inflammatory Arthritis – Results of a Randomized Controlled Trial

    Andre Luquini1, Yufei Zheng2, Hui Xie2, Catherine L. Backman3, Pamela Rogers4, Alex Kwok4, Astrid Knight4, Monique Gignac5, Dianne Mosher6, Linda Li3, John Esdaile7, Carter Thorne8 and Diane Lacaille2, 1University of British Columbia / Arthritis Research Canada, Fort Saint John, BC, Canada, 2Arthritis Research Canada, Richmond, BC, Canada, 3University of British Columbia, Vancouver, BC, Canada, 4Arthritis Research Canada / UBC, Vancouver, BC, Canada, 5Institute for Work & Health, Toronto, ON, Canada, 6University of Calgary, Calgary, AB, Canada, 7Arthritis Research Canada, Vancouver, BC, Canada, 8Southlake Regional Health Centre, Newmarket, ON, Canada

    Background/Purpose: Despite advances in treatment, absenteeism remains a major problem for workers living with inflammatory arthritis (IA), leading to reduced income and quality of life.…
  • Abstract Number: 0227 • ACR Convergence 2021

    Work Participation Is Impaired Months Before Clinical Arthritis Is Apparent

    Cleo Rogier1, Pascal de Jong2, Annette H.M van der Helm-van Mil3 and Elise van Mulligen4, 1Erasmus MC, Rotterdam, 2Erasmus MC, Hendrik Ido Ambacht, Netherlands, 3Leiden University Medical Center, Leiden, Netherlands, 4Erasmus Medical Center, Rotterdam, Netherlands

    Background/Purpose: Work participation is still a major issue for patients with rheumatoid arthritis (RA) despite improved management and outcomes. Work loss can be divided into…
  • Abstract Number: 0360 • ACR Convergence 2021

    Factors Associated with Pain Intensity in Axial Spondyloarthritis. Results from the EuropeanMap of Axial Spondyloarthritis (EMAS)

    Marco Garrido-Cumbrera1, Victoria Navarro-Compán2, Christine Bundy3, Laura Christen4, Raj Mahapatra5, Souzi Makri6, Carlos Jesús Delgado-Domínguez7, José Correa-Fernández7, Pedro Plazuelo-Ramos8 and Denis Poddubnyy9, 1Health & Territory Research (HTR), University of Seville, Sevilla, Spain, 2Rheumatology service, Hospital Universitario La Paz-IdiPaz, Madrid, Spain, 3Cardiff University, Cardiff, Wales, United Kingdom, 4Novartis Pharma AG, Basel, Switzerland, 5Axial Spondyloarthritis International Federation (ASIF), London, United Kingdom, 6Cyprus League Against Rheumatism (CYPLAR), Limassol, Cyprus, 7Health & Territory Research (HTR), Universidad de Sevilla, Seville, Spain, 8Spanish Federation of Spondyloarthritis Associations (CEADE), Madrid, Spain, 9Department of Rheumatology, Charité – Universitätsmedizin, Berlin, Germany

    Background/Purpose: Pain is a hallmark of axial spondyloarthritis (axSpA) and can significantly deteriorate patients’ health status. This analysis aims to investigate factors associated with pain…
  • Abstract Number: 0366 • ACR Convergence 2021

    Why Is It so Difficult for AxSpA Patients to Find a Job? Results from the European Map of Axial Spondyloarthritis (EMAS)

    Marco Garrido-Cumbrera1, Victoria Navarro-Compán2, Christine Bundy3, Souzi Makri4, Laura Christen5, José Correa-Fernández6, Sergio Sanz-Gomez6, Raj Mahapatra7, Carlos Jesús Delgado-Domínguez6 and Denis Poddubnyy8, 1Health & Territory Research (HTR), University of Seville, Sevilla, Spain, 2Rheumatology service, Hospital Universitario La Paz-IdiPaz, Madrid, Spain, 3Cardiff University, Cardiff, Wales, United Kingdom, 4Cyprus League Against Rheumatism (CYPLAR), Limassol, Cyprus, 5Novartis Pharma AG, Basel, Switzerland, 6Health & Territory Research (HTR), Universidad de Sevilla, Seville, Spain, 7Axial Spondyloarthritis International Federation (ASIF), London, United Kingdom, 8Department of Rheumatology, Charité – Universitätsmedizin, Berlin, Germany

    Background/Purpose: AxSpA is associated with substantial negative consequences regarding work status and career prospects. The aim is to identify factors associated with barriers to job…
  • Abstract Number: 0810 • ACR Convergence 2021

    Persistent Disease Activity Impairs Work Productivity and Non-work Activity in Recent Onset Rheumatoid Arthritis

    Carol Hitchon1, Marie-France Valois2, Orit Schieir3, Susan Bartlett2, Louis Bessette4, Gilles Boire5, Glen Hazlewood6, Edward Keystone7, Janet Pope8, Carter Thorne9, Diane Tin10, Vivian Bykerk11 and Canadian Early Arthritis Cohort (CATCH) Investigators12, 1University of Manitoba, Winnipeg, MB, Canada, 2McGill University, Montréal, QC, Canada, 3Canadian Early Arthritis Cohort Study, Montréal, QC, Canada, 4Centre de l'Ostoporose et de Rhumatologie de Qubec, Québec City, QC, Canada, 5Universite de Sherbrooke, Sherbrooke, QC, Canada, 6University of Calgary, Calgary, AB, Canada, 7Keystone Consulting Enterprises Inc., Toronto, ON, Canada, 8University of Western Ontario, London, ON, Canada, 9Southlake Regional Health Centre, Newmarket, ON, Canada, 10The Arthritis Program Research Group, Newmarket, ON, Canada, 11Hospital for Special Surgery, New York, NY, 12Canadian Early Arthritis Cohort, Toronto, ON, Canada

    Background/Purpose: Reduced work and activity productivity are significant contributors to the personal and societal costs associated with rheumatoid arthritis (RA). We sought to describe work…
  • Abstract Number: 1077 • ACR Convergence 2021

    Effectiveness of Non-Pharmacological Interventions to Promote Work Participation of People with Rheumatic and Musculoskeletal Diseases: A Systematic Review and Meta-Regression Analysis

    Maarten Butink1, Casper Webers2, Suzanne Verstappen3, Robin Christensen4, Louise Falzon5, Johannes Bijlsma6, Gerd Burmester7 and Annelies Boonen2, 1Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Centre+ (MUMC+); Department of Social Medicine, Care and Public Health Research Institute (CAPHRI), Maastricht, Limburg, Netherlands, 2Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Centre+ (MUMC+), Maastricht, Limburg, Netherlands, 3School of Social Sciences, The University of Manchester, Manchester, United Kingdom, 4Section for Biostatistics and Evidence-Based Research, the Parker Institute, Bispebjerg and Frederiksberg Hospital, Copenhagen & Research Unit of Rheumatology, Department of Clinical Research, University of Southern Denmark, Copenhagen, Denmark, 5Center for Personalized Health, Northwell Health, New York City, NY, 6Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht, Netherlands, 7Charité University Medicine Berlin, Berlin, Germany

    Background/Purpose: Despite improvements in the treatment of rheumatic and musculoskeletal diseases (RMDs), reduced work participation persists when compared to the general population. A Task Force…
  • Abstract Number: 1118 • ACR Convergence 2021

    The Association of Hand OA with Paid an Unpaid Work Impairment and Related Costs: The Hand Osteoarthritis in Secondary Care Cohort

    Sietse Terpstra1, Lotte van de Stadt1, Annelies Boonen2, Frits Rosendaal1 and Margreet Kloppenburg1, 1Leiden University Medical Center, Leiden, Netherlands, 2Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Centre+ (MUMC+), Maastricht, Limburg, Netherlands

    Background/Purpose: Rheumatic musculoskeletal diseases (RMDs) can cause impairment at paid and unpaid work and contributes to societal burden and costs. However, data on this topic…
  • Abstract Number: 1186 • ACR Convergence 2021

    The Kardashian Index of Rheumatology Program Directors: Comparing Scholarly Activity and Twitter Use of Rheumatology Fellowship Program Directors in the United States

    Aakanksha Khanna1, Keerthy Gopalakrishnan2, Dawid Czarny1, Brian Quigley1 and Alysia Kwiatkowski1, 1State University of New York at Buffalo, Buffalo, NY, 2S.R.M. Medical College Hospital and Research Center, Buffalo, NY

    Background/Purpose: Social media has changed the way we communicate and disseminate information. Program directors (PDs) can use social media to boost visibility for professional networking,…
  • Abstract Number: 1187 • ACR Convergence 2021

    Is Your Program Website Optimized for Recruitment? An Evaluation of Rheumatology Fellowship Program Websites

    Temitope Ajayi, Aakanksha Khanna, Brian Quigley and Alysia Kwiatkowski, State University of New York at Buffalo, Buffalo, NY

    Background/Purpose: A program’s website is a helpful source of information for a prospective applicant whose decision on where to apply is influenced by the data…
  • Abstract Number: 0165 • ACR Convergence 2020

    Work Disability and Predictors of Poor Work Outcome in Patients with Axial Spondyloarthritis

    Elif Ediboglu1, Dilek Solmaz2, Hande Ece Oz3, Gokhan Kabadayı4, Haluk Cinaklı4, Eda Otman Akat3, Mustafa Ozmen4 and Servet Akar3, 1Izmir Katip Celebi University, Izmir, Izmir, Turkey, 2Izmir Katip Celebi University, Department of Internal Medicine, Division of Rheumatology, Izmir, TURKEY, Izmir, Turkey, 3Izmir Katip Celebi University, Izmir, Turkey, 4Izmir Katip Celebi University, Izmir

    Background/Purpose: Axial spondyloarthritis (axSpA) is a chronic inflammatory disease which may lead substantial functional limitation. The disease more commonly affects men in their third decade…
  • Abstract Number: 0326 • ACR Convergence 2020

    Flares Among Patients with Psoriatic Arthritis (PsA) – Frequency and Impact on Patient Outcomes: Real-world Survey in the US and Europe

    Ana-Maria Orbai1, William Tillett2, Suzann Grieb3, James Piercy4, Steven Peterson5, Elizabeth Holdsworth4, Sophie Meakin4, Soumya Chakravarty6, Nicola Booth4 and Laure Gossec7, 1Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, 2Royal National Hospital for Rheumatic Diseases, Bath, UK; Department of Pharmacy and Pharmacology, University of Bath, Bath, UK, Bath, United Kingdom, 3John Hopkins University School of Medicine, Baltimore, 4Adelphi Real World, Bollington, United Kingdom, 5Janssen Immunology Global Commercial Strategy Organization, Horsham, PA, 6Janssen Scientific Affairs, LLC, Horsham, PA, USA and Drexel University College of Medicine, Horsham, PA, 7Sorbonne University, INSERM; Pitié-Salpêtrière Hospital, Paris, Ile-de-France, France

    Background/Purpose: Flares in PsA, presenting as periods of acute disease activity, are thought to negatively impact patients’ lives. This has not been extensively studied in…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology